|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12P 21/02 | |
| C12N 15/81 | |||
| C07K 14/62 |
| (11) | Patento numeris | 2831262 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12872941.5 |
| Europos patento paraiškos padavimo data | 2012-06-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-02-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/052853 |
| Data | 2012-06-06 |
| (87) | Numeris | WO 2013/144685 |
| Data | 2013-10-03 |
| (30) | Numeris | Data | Šalis |
| CH12282012 | 2012-03-29 | IN |
| (72) |
GOVINDAPPA, Nagaraj, IN
SREENIVAS, Suma, IN
KANOJIA, Komal, N, IN
BASAVARAJU, Yogesh, IN
SASTRY, Kedarnath, Nanjund, IN
|
| (73) |
Biocon Limited,
20th K.M. Hosur Road, Electronic City P.O., Bangalore 560 100,
IN
|
| (54) | SECRETION OF FUNCTIONAL INSULIN GLARGINE DIRECTLY INTO THE CULTURE MEDIUM THROUGH OVER EXPRESSION OF KEX2P INTRACELLULARLY |
| SECRETION OF FUNCTIONAL INSULIN GLARGINE DIRECTLY INTO THE CULTURE MEDIUM THROUGH OVER EXPRESSION OF KEX2P INTRACELLULARLY |